Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507413 | PMC |
| http://dx.doi.org/10.3389/ftox.2023.1248748 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial Expression of Concern: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
Oncogene
January 2025
Department of Women's Health Educational System, Hokkaido University School of Medicine, Hokkaido University, Sapporo, 0608638, Japan.
Addressing Mental Health in Obstetrics and Gynecology.
Obstet Gynecol Clin North Am
March 2025
Department of Obstetrics and Gynecology and Women's Health (Maternal Fetal Medicine), Montefiore Medical Center, Division of Maternal Fetal Medicine, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address:
IVF in women with low ovarian reserve or response.
BMJ
January 2025
Amsterdam UMC, University of Amsterdam, Centre for Reproductive Medicine, Amsterdam, Netherlands.
Writing for publication: The basics.
Women Birth
January 2025
Midwifery, Child and Family Health, University of Technology Sydney, NSW, Australia.
Problem: Writing for publication can be a challenging experience. Whilst midwives develop writing skills through their university education, writing a journal article can be quite different.
Purpose: To explain some basic skills of scientific writing when preparing a paper for publication to support midwives in engaging in scientific writing.
What happens after menopause? (WHAM): A prospective controlled study of cognition 24 months after premenopausal risk-reducing salpingo-oophorectomy.
Gynecol Oncol
January 2025
Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne and The Royal Women's Hospital, Melbourne, Victoria, Australia. Electronic address:
Objective: Women with BRCA1/2 pathogenic variants considering risk-reducing bilateral oophorectomy (RRSO) may be concerned about potential effects of surgical menopause on cognition. Whether RRSO affects cognition and whether hormone therapy (HT) modifies this effect remains uncertain. This study aimed to prospectively measure the effect of premenopausal RRSO on cognition and the modifying effects of HT up to 24 months.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!